Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-06-2009 | Letter to the Editor

Lack of association of VEGF (−2578 C → A) and ANG 2 (−35 G → C) gene polymorphisms with the progression of retinopathy of prematurity

Author: Barkur S. Shastry

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2009

Excerpt

Dear Editor: …

Shastry BS, Pendergast D, Hartzer MK, Liu X, Trese MT (1997) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 115:651–656PubMed

Haider MZ, Devarajan LV, Al-Essa M, Kumar HA (2002) A C597A polymorphism in the Norrie disease gene is associated with advance retinopathy prematurity in Kuwaiti infants. J Biomed 9:365–370

Hutcheson KA, Paluru PC, Bernstein SL, Koh J, Rappaport EF, Leach RA, Young TL (2005) Norrie disease gene sequence variants in an ethically diverse population with retinopathy of prematurity. Mol Vis 11:501–508PubMed

Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V (2006) Genetic susceptibility to retinopathy of prematurity. Pediatrics 118:1858–1863. doi:10.1542/peds.2006-1088 PubMedCrossRef

Alon T, Hemo I, Itin A, Peer J, Stone J, Kesht E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications to retinopathy of prematurity. Nat Med 1:1024–1028. doi:10.1038/nm1095-1024 PubMedCrossRef

Sonmez K, Drenser KA, Capone A, Trese MT (2008) Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmol 115:1065–1070. doi:10.1016/j.ophtha.2007.08.050 CrossRef

Cook RWI, Drury JA, Mountford R, Clark D (2004) Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45:1712–1715. doi:10.1167/iovs.03-1303 CrossRef

Vannay A, Dunai G, Banyasz I, Szabo M, Vamos R, Treszl A, Hajdu J, Tulassay T, Vasarhelyi B (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57:396–398. doi:10.1203/01.PDR.0000153867.80238.E0 PubMedCrossRef

Banyasz I, Bokodl G, Vannay A, Szebeni B, Treszl A, Vasarhelyi B, Tulassay T, Szabo A (2006) Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res 31:685–690. doi:10.1080/02713680600801123 PubMedCrossRef

10.

Dunai G, Vasarhelyi B, Szabo M, Hajdu J, Meszaros G, Tulassay T, Treszl A (2008) Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 33:501–505PubMedCrossRef

Title: Lack of association of VEGF (−2578 C → A) and ANG 2 (−35 G → C) gene polymorphisms with the progression of retinopathy of prematurity
Author: Barkur S. Shastry
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2009
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-008-0988-z

At a glance: The STEP trials

Springer Medicine

Lack of association of VEGF (−2578 C → A) and ANG 2 (−35 G → C) gene polymorphisms with the progression of retinopathy of prematurity

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2009

The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy

G.O.H Naumann, LM Holbach, F.E. Kruse: Applied Pathology for Ophthalmic Microsurgeons

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up

Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies

Distance doubling visual acuity test: A reliable test for nonorganic visual loss

Cerebrospinal fluid pressure and glaucomatous optic disc cupping